EUVIMEDEUVIMED entdecken
Open Access

Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models

Jihwan Moon, Vu T A Vo, Le Tran Nhat, Minseob Eom, Yangsik Jeong

The Korean Journal of Physiology & Pharmacology · 01.01.2026 · 30 (1) · 41-48

DOI: 10.4196/kjpp.25.355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Korean Journal of Physiology & Pharmacology, online erschienen am 01.12.2025. Verfasst von Jihwan Moon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Discoidin domain receptor 2Drug repositioningExtracellular matrixRenal cell carcinomaTyrosine kinase inhibitors

Autor:innen und Institutionen

  • Department of Pathology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
  • Department of Biochemistry, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
  • Department of Global Medical Science, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
  • ONCOin, Ltd., Chuncheon 24341, Korea.

Zitieren

APA

Moon, J., Vo, V. T. A., Nhat, L. T., Eom, M., & Jeong, Y. (2026). Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models. The Korean Journal of Physiology & Pharmacology, 30(1), 41-48. https://doi.org/10.4196/kjpp.25.355

Vancouver

Moon J, Vo VTA, Nhat LT, Eom M, Jeong Y. Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models. The Korean Journal of Physiology & Pharmacology. 2026;30(1):41-48. doi:10.4196/kjpp.25.355

BibTeX
@article{Moon2026,
  author = {Moon, Jihwan and Vo, Vu T A and Nhat, Le Tran and Eom, Minseob and Jeong, Yangsik},
  title = {Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models},
  journal = {The Korean Journal of Physiology & Pharmacology},
  year = {2026},
  volume = {30},
  number = {1},
  pages = {41--48},
  doi = {10.4196/kjpp.25.355}
}
Kostenlos starten →